Floatz logo

Tadalafil

Prostatic Hyperplasia, Benign

University of FlorenceSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Prostatic Hyperplasia, Benign cohort.

Asset / SponsorPhaseRating
AVOLVE
Turku University Hospital
Phase 4BB
DINITROGEN MONOXIDE
Beth Israel Deaconess Medical Center
Phase 4BB
TESTOSTERONE UNDECYLATE
University of Florence
Phase 4BB
Oxygen
Beth Israel Deaconess Medical Center
Phase 4BB
DICLOFENAC
Taha Uçar
Phase 4BB

View all 17 →

Same molecule, other indications

Tadalafil is also rated in:

sexual disorderDormant
BBB
Indicative ·
72 / 100
View asset →
erectile dysfunctionDormant
BB
Indicative ·
69 / 100
View asset →
Duchenne muscular dystrophyDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →